{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T04:01:34Z","timestamp":1745812894930,"version":"3.40.4"},"reference-count":20,"publisher":"BMJ","funder":[{"DOI":"10.13039\/100008578","name":"Georgia Regents University","doi-asserted-by":"publisher","award":["Institution Start up for CS and ZH"],"award-info":[{"award-number":["Institution Start up for CS and ZH"]}],"id":[{"id":"10.13039\/100008578","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2016,6,23]]},"abstract":"<jats:p>A 58-year-old woman, a heavy smoker, was diagnosed with stage III squamous cell lung cancer. She was treated with concurrent chemotherapy and radiotherapy, with partial response. 2\u2005months later, she had haemoptysis caused by brisk bleeding from the radiated right upper lobe. Fortunately, her bleed was self-limited. 4\u2005months later, a rapidly enlarging renal mass was discovered and turned out to be metastatic from the lung primary. Second-line chemotherapy with docetaxel and ramucirumab did not have effects on the renal mass after 2 cycles. Despite not being eligible for a durvalumab trial because of lack of PD-L1 expression, she had a meaningful response to nivolumab. Once every 2\u2005weeks, infusion of nivolumab resulted in rapid tumour shrinkage in multiple areas. In the next few months, she experienced a variety of side effects, some of which were potentially life-threatening. She had disease progression 9\u2005months into treatment.<\/jats:p>","DOI":"10.1136\/bcr-2016-215304","type":"journal-article","created":{"date-parts":[[2016,7,7]],"date-time":"2016-07-07T17:54:32Z","timestamp":1467914072000},"page":"bcr2016215304","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Battling regional (stage III) lung cancer: bumpy road of a cancer survivor in the immunotherapy age"],"prefix":"10.1136","volume":"2016","author":[{"given":"Zhonglin","family":"Hao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Biddinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khurram","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2016,7,7]]},"reference":[{"key":"2025042703421658000_2016.jul07_1.bcr2016215304.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1204410"},{"key":"2025042703421658000_2016.jul07_1.bcr2016215304.2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.62.1342"},{"key":"2025042703421658000_2016.jul07_1.bcr2016215304.3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.2360"},{"key":"2025042703421658000_2016.jul07_1.bcr2016215304.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810699"},{"key":"2025042703421658000_2016.jul07_1.bcr2016215304.5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.33.4235"},{"key":"2025042703421658000_2016.jul07_1.bcr2016215304.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214886"},{"key":"2025042703421658000_2016.jul07_1.bcr2016215304.7","doi-asserted-by":"crossref","unstructured":"Shaw AT , Ou SH , Bang YJ , et al . Crizotinib in ROS1-rearranged non-small-cell lung cancer. N Engl J Med 2014;371 (21):1963\u20131. doi:10.1056\/NEJMoa1406766","DOI":"10.1056\/NEJMoa1406766"},{"key":"2025042703421658000_2016.jul07_1.bcr2016215304.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504627"},{"key":"2025042703421658000_2016.jul07_1.bcr2016215304.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1507643"},{"key":"2025042703421658000_2016.jul07_1.bcr2016215304.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501824"},{"key":"2025042703421658000_2016.jul07_1.bcr2016215304.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01281-7"},{"key":"2025042703421658000_2016.jul07_1.bcr2016215304.12","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21254"},{"key":"2025042703421658000_2016.jul07_1.bcr2016215304.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.thorsurg.2014.12.003"},{"key":"2025042703421658000_2016.jul07_1.bcr2016215304.14","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000060"},{"key":"2025042703421658000_2016.jul07_1.bcr2016215304.15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.8126"},{"key":"2025042703421658000_2016.jul07_1.bcr2016215304.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60845-X"},{"key":"2025042703421658000_2016.jul07_1.bcr2016215304.17","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/annonc\/mdv623","article-title":"Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper","volume":"27","author":"Champiat","year":"2015","journal-title":"Ann Oncol"},{"key":"2025042703421658000_2016.jul07_1.bcr2016215304.18","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000526"},{"key":"2025042703421658000_2016.jul07_1.bcr2016215304.19","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-1624"},{"key":"2025042703421658000_2016.jul07_1.bcr2016215304.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1000678"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2016-215304","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T10:42:26Z","timestamp":1745750546000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2016-215304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,7]]},"references-count":20,"alternative-id":["10.1136\/bcr-2016-215304"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2016-215304","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2016,7,7]]}}}